Legend Biotech Corporation

NASDAQ:LEGN

Biotechnology

Healthcare
$16.10 -13.51%

-$4.53 today

Market cap
$2.98B
Beta
0.35
P/E (TTM)
-21.4
EPS (TTM)
-$1.35
52W Low $16.24High $45.30

Volume 2.37M

Average 2.42M

Balance Sheet

Inspect the capital base behind the business.

Assets

$1.73B

FY 2025 · Annual

+3.8% YoY

Liabilities

$731.60M

FY 2025 · Annual

+16.2% YoY

Equity

$1.00B

FY 2025 · Annual

-3.7% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents688.94M786.03M1.28B286.75M901.9M
Short-term Investments193.46M239.62M31M835.93M46.7M
Net Receivables58.55M44.52M157.06M124.89M250.3M
Inventory1.75M10.35M19.43M23.9M32M
Other Current Assets1.44M1.27M357K70K1.6M
Total Current Assets949.85M1.1B1.5B1.28B1.25B
Property, Plant & Equipment (Net)142.96M161.67M189.68M201.59M402M
Goodwill00000
Intangible Assets16.81M68.69M4.06M174.22M74.6M
Long-term Investments4.71M04.36M4.36M5M
Tax Assets00285K00
Other Non-current Assets5.15M1.49M152.42M6.06M5M
Total Non-current Assets169.62M231.84M350.81M386.24M486.6M
Total Assets1.12B1.33B1.85B1.67B1.73B
Account Payables7.04M31.69M20.16M37.19M81.2M
Short-term Debt0000319.1M
Tax Payables10M10.79M7.2M24.04M0
Deferred Revenue304K451K53.01M47.41M11.3M
Other Current Liabilities87.9M67M68K500K1M
Total Current Liabilities229.2M297.79M216.42M277.65M636.4M
Long-term Debt120.46M260.93M281.33M301.2M0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)1.87M7.66M55.27M6.15M0
Other Non-current Liabilities396K233K56K(54K)8M
Total Non-current Liabilities124.32M288.86M380.82M351.96M95.2M
Total Liabilities353.52M586.65M597.24M629.61M731.6M
Common Stock31K33K36K37K100K
Retained Earnings(520.11M)(966.46M)(1.48B)(1.66B)(1.96B)
Accumulated OCI4.86M14.67M98.93M(68.16M)122.2M
Other Stockholders Equity19.7M39.05M074.43M88M
Minority Interest00000
Total Equity765.94M744.31M1.25B1.04B1B
Total Debt122.97M284.53M328.67M350.6M413.7M
Net Debt(565.97M)(501.5M)(949.04M)63.85M(488.2M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$460.7M
Short-term Investments$391.8M
Receivables$218.9M
Inventory$39.8M
Other Current$33.6M
Total Current Assets$1.1B
PP&E (Net)$439.5M
Intangible Assets$71.3M
Other Non-current$25.8M
Total Non-current Assets$536.6M
Total Assets$1.7B

Analysis

Selected assets total $1.7B for Latest. The largest visible component is Cash & Equivalents at $460.7M, about 27.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 10, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
6-K6-K filingNov 4, 2026
6-K6-K filingOct 15, 2026
6-K6-K filingOct 13, 2026

How much cash does LEGN have?

Legend Biotech Corporation (LEGN) reported $901.90M in cash and equivalents in fiscal 2025.

How much debt does LEGN carry?

Legend Biotech Corporation (LEGN) reported $413.70M of total debt, with net debt of -$488.20M.